Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ABX203 for maintenance of control in chronic hepatitis B after nucleos(t)ide analog cessation (Asia-Pacific)
KCT0001706Phase 3Terminated
- Sponsor
- Abivax
- Start
- Aug 2015
- Modality
- Vaccines & Immunotherapeutics, Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of ABX203 in Chronic Hepatitis B (CHB), sponsored by Abivax. Started Aug 2015; status: terminated.
02
Drugs
ABX203
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on KCT0001706.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on KCT0001706.